Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Looking to boost your income? Discover effective ways to increase income quickly with our expert tips.
21,712 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
Tesla faces a pivotal three-year outlook as margins recover and AI initiatives expand. Analysts sketch a base case ar...
This week brought a burst of excitement around Criteo as takeover chatter swirled and the stock jumped. We break down...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A single chokepoint can reshape markets. When the strait hormuz closure sent oil prices higher, energy shares jumped ...
Britain designated the IRGC on July 17, expanding criminal exposure for crypto firms that handle or retain value link...
Copper futures tumbled intraday as supply climbs and demand questions linger. The move pins attention on five NYSE-li...
As markets swing into February 2026, a core group of performing cash stocks on Cash App are leading gains. This repor...
President Trump announces a new tariff package under a different statute, prompting questions about legality and mark...
Bitcoin and Ethereum lead a broad crypto rebound as on-chain data shows heavy whale buying. XRP and major altcoins ra...
BITW fell 22.4% year-to-date through Feb. 25, 2026, tracking Bitcoin's drop and highlighting how diversification acro...